Solvac S.A.

Solvac S.A.

SOLV.BR
Solvac S.A.BE flagEuronext Brussels
73.00
EUR
- -
- -
1.56BMarket Cap
Solvac S.A.
SOLV.BR
(Euronext Brussels)

Recent

price

73.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
33.37
4.35
10.16
4.72
1.15
5.66
8.89
15.35
12.68
1.5
-14.6
13.71
5.71
5.96
4.9
- -
Basic EPS, GAAP
4.46
3.14
4.72
4.96
4.84
4.07
5.01
5.19
5.43
5.66
5.47
5.61
5.85
-0.22
-0.14
- -
Free Cash Flow per Basic Share
3.98
5.5
4.17
4.35
4.35
3.6
4.82
5.01
5.24
5.43
5.43
5.43
5.57
5.81
5.81
- -
Dividend per Share
8.33
128.55
134.35
134.42
130.06
102.36
105.12
113.64
119.39
114.25
92.63
100.02
74
74.15
73.24
- -
Book Value per Share
111.26
108.86
106.06
123.77
114.83
130.48
135.3
134.27
147.37
132.49
98.57
120.84
118.52
118.69
117.77
- -
Tangible Book Value per Share
17
17
17
17
17
21
21
21
21
21
21
21
21
21
21
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
553
72
168
78
19
121
190
328
271
32
-312
293
122
127
105
125
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-25
-24
-25
-17
-14
-17
-5
-3
-12
-9
-19
-18
-15
-12
-81
-30
Working Capital
110
110
110
110
110
110
160
160
150
150
150
150
150
150
100
150
LT Debt
2,186
2,143
2,096
2,389
2,241
3,131
3,235
3,213
3,493
3,175
2,450
2,926
2,533
2,536
2,516
2,518
Total Equity
-0.05
-0.04
-0.04
-0.04
-0.04
-0.04
-0.06
-0.03
-0.03
-0.03
- -
-0.07
-0.07
-0.09
-0.09
-0.12
Return on Invested Capital (%)
223.2
6.08
7.42
3.49
0.98
5.37
8.09
13.12
10.25
1.34
- -
13.1
6.07
7.32
6.16
7.46
Return on Capital (%)
400.72
6.35
7.72
3.51
0.87
5.58
8.57
14.03
10.88
1.28
-14.11
14.23
6.56
8.05
6.65
8
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-1.52%
1.08%
0.04%
Free Cash Flow
-7.19%
-20.83%
28.48%
Net Income, GAAP
-129.69%
-49.2%
19.69%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
5.96
2024
- -
- -
- -
- -
4.9
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
5.81
2024
- -
- -
- -
- -
5.81
2025
- -
- -
- -
- -
- -
Business
Solvac S.A. is a Belgian holding company primarily engaged in managing significant long-term strategic equity investments, notably a majority stake of approximately 30.8% in Solvay S.A., a global leader in advanced materials and specialty chemicals, and a substantial stake in Syensqo S.A., which also operates in specialty chemicals. Founded in 1983 and headquartered in Brussels, Solvac does not directly manufacture products but derives its core business from its portfolio holdings in manufacturing and marketing of specialty polymers, composite materials, soda ash, peroxides, silica, coatings, plastics, chemicals, and pharmaceutical products through these subsidiaries. The company's mission centers on supporting the sustainable growth and value creation of these invested entities, which serve end markets including automotive, aerospace, electronics, medical devices, and energy sectors worldwide. Recent developments include Solvac's ongoing role as a stable reference shareholder, facilitating strategic initiatives and growth in its portfolio companies, with no recent reports of new product launches directly by Solvac but significant shareholder activity and dividend announcements reflecting its financial health and strategic positioning as an investment vehicle in advanced materials and chemical industries. Solvac operates mainly in Belgium but its investment reach and market influence are global through its holdings. The company employs a minimal direct workforce, acting as a financial and strategic holding entity rather than an operational manufacturer. This structure positions Solvac as a key investor and stabilizing force within the specialty chemicals and advanced materials sectors, focusing on shareholder returns through its controlling interests and strategic oversight of its portfolio companies' innovation and expansion efforts.